Susquehanna International Group, LLP Spero Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 44,219 shares of SPRO stock, worth $51,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,219

Previous 23,073 91.65%

Holding current value

$51,294

Previous $29,000 103.45%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.19 - $1.5 $25,163 - $31,719	21,146 Added 91.65%	44,219 $59,000
Q2 2024 Aug 15, 2024	BUY	$1.27 - $1.8 $29,302 - $41,531	23,073 New	23,073 $29,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.47 $2,097 - $3,082	-2,097 Reduced 10.39%	18,086 $26,000
Q3 2023 Nov 14, 2023	SELL	$1.2 - $1.63 $29,011 - $39,406	-24,176 Reduced 54.5%	20,183 $24,000
Q2 2023 Aug 11, 2023	BUY	$1.42 - $1.95 $25,297 - $34,739	17,815 Added 67.11%	44,359 $64,000
Q1 2023 May 16, 2023	SELL	$1.35 - $2.0 $32,541 - $48,210	-24,105 Reduced 47.59%	26,544 $38,000
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.12 $28,887 - $39,510	-18,637 Reduced 26.9%	50,649 $87,000
Q3 2022 Nov 14, 2022	BUY	$0.68 - $2.2 $10,295 - $33,310	15,141 Added 27.96%	69,286 $139,000
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $9,574 - $96,266	-12,939 Reduced 19.29%	54,145 $40,000
Q1 2022 May 16, 2022	SELL	$7.87 - $15.15 $63,739 - $122,699	-8,099 Reduced 10.77%	67,084 $584,000
Q4 2021 Feb 14, 2022	BUY	$13.09 - $18.77 $463,844 - $665,114	35,435 Added 89.15%	75,183 $1.2 Million
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $22,281 - $33,362	-1,710 Reduced 4.12%	39,748 $732,000
Q2 2021 Aug 11, 2021	SELL	$12.22 - $15.79 $338,799 - $437,777	-27,725 Reduced 40.07%	41,458 $579,000
Q1 2021 May 17, 2021	SELL	$13.23 - $21.48 $64,760 - $105,144	-4,895 Reduced 6.61%	69,183 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$11.65 - $22.07 $194,205 - $367,906	16,670 Added 29.04%	74,078 $1.44 Million
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $153,735 - $242,270	17,158 Added 42.63%	57,408 $641,000
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $292,617 - $570,745	40,250 New	40,250 $545,000
Q4 2019 Feb 14, 2020	SELL	$9.46 - $12.16 $104,655 - $134,526	-11,063 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.01 - $12.55 $99,677 - $138,840	11,063 New	11,063 $117,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $40.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Spero Therapeutics, Inc. Transaction History